Badgley, Phelps & Bell’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Badgley, Phelps & Bell's LLY Position: Q2 2021 in Review
Badgley, Phelps & Bell increased its Eli Lilly (LLY) stake by 1.6% in Q2 2021, buying an estimated $308K and bringing the position to 94,988 shares worth $21.8M. The position accounts for 0.81% of the portfolio, ranked #41.
Badgley, Phelps & Bell first reported a position in LLY in Q1 2017 and has held it in 18 quarters since. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.
- Badgley, Phelps & Bell held 94,988 shares of Eli Lilly worth $21.8M as of Q2 2021.
- Badgley, Phelps & Bell bought 1,535 Eli Lilly shares in Q2 2021, an estimated $308K.
- Eli Lilly made up 0.81% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #41 holding.
- Badgley, Phelps & Bell first reported a position in Eli Lilly in Q1 2017 and has held it in 18 quarters since.
- 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.
Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.